Signal active
Bio
John Westwater is the Chief Financial Officer at Elastagen Pty Ltd. since 2015. John has over thirteen years experience in the life science financial industry, eight years as a venture capital investor and remainder as an investment banking professional.
Prior to joining Elastagen John was at Phase4 Ventures (formerly Nomura Phase4 Ventures), a global life science VC firm based in London. During this period he was actively involved with several investments both in the US and Europe: including Nabriva Therapeutics, Paratek Pharmaceuticals, Zosano Pharma and Acadia Pharmaceuticals.
John has also spent over four years with Morgan Stanley in their healthcare corporate finance and Mergers & Acquisitions teams. During this period he had a key role in the development and execution of Elan Corp’s recovery plan between 2002 and 2003, which involved over $1Bn in disposal proceeds and the restructuring of its balance sheet, as well as several biotech initial public offerings.
John holds a Ph.D. and B.Sc. degree (Hons) in Biochemistry from Heriot-Watt University in Scotland and was awarded the Watt Club Medal.
Location
Sydney, New South Wales, Australia, Oceania
Social
Primary Organization
2006
67
27
8
11-50
Venture Capital
Jobs history
1
OneVentures
Principal
2020 - Current
Board and Advisor Roles
0
N/A
Invest in regions
Profile Resume
John Westwater is the Principal at OneVentures, based in Sydney, New South Wales, Australia, Oceania. With a background in Venture Capital, John Westwater has a rich history of leadership and innovation. John Westwater studied Ph.D. Biochemistry @ Heriot-Watt University. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.
Recommendation from your interest
N/A
Investment portfolio
1
0
Personal investment
0
There is no personal investment available on this profile
Partner investment
0
There is no partner investment available on this profile
Exits
0
There is no exit available on this Profile
Invest in industries
Recent Activity
There is no recent news or activity for this profile.